Hyderabad, Nov. 22

Aurobindo Pharma Ltd (APL) has received fiveproduct approvals from the US Food & DrugAdministration (USFDA) since October 2007 for the USmarket. These approvals include two Paragraph IVproducts - Finasterice Tablets USP and Glyburide &Metformin Hydrochloride Tablets. According to theHyderabad-based APL, the products approved are asfollows: Glyburide Tablets USP, Torsemide tablets;Finasteride tablets; Atenolol tablets, and Glyburide andMefformin Hydrochloride tablets in various dosages.With these approvals the company now has a total of 59ANDAs (abbreviated new drug approvals )approved bythe USFDA. - Our Bureau

(This article was published in the Business Line print edition dated November 23, 2007)
XThese are links to The Hindu Business Line suggested by Outbrain, which may or may not be relevant to the other content on this page. You can read Outbrain's privacy and cookie policy here.